Nurse Practitioner, Psychiatric/Mental Health · Hastings, NE
NPI
1013271246
Since 2012
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
224 E 14th St. Ste 100
Hastings, NE, 68901
Phone (402) 463-2929
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
646 services
Medicare patients, 2024
134
Average age 68
Drug cost, 2024
$658K
3,819 prescriptions
Company payments, 2025
$8,451
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dacia D Oakeson was code 99214 (office e&m - established), 99 times for 43 patients. In total Dacia D Oakeson billed 646 services in 44 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 99 | 43 | $61.75 | $6,113 |
| 99232 Hospital E&M - Subsequent | Office | 72 | 35 | $48.05 | $3,460 |
| 36415 Venipuncture Blood Collection | Office | 62 | 31 | $6.86 | $425 |
| 99233 Hospital E&M - Subsequent | Office | 47 | 30 | $72.09 | $3,388 |
| 99213 Office E&M - Established | Office | 27 | 20 | $48.90 | $1,320 |
| 99231 Hospital E&M - Subsequent | Facility | 27 | 13 | $30.23 | $816 |
| 99231 Hospital E&M - Subsequent | Office | 27 | 11 | $29.97 | $809 |
| 83036 Blood Count | Office | 26 | 16 | $9.52 | $248 |
| 80061 Clinical Chemistry | Office | 24 | 21 | $13.12 | $315 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 23 | 23 | $102.32 | $2,353 |
| 85025 Blood Count | Office | 22 | 19 | $7.61 | $167 |
| 96127 Behavioral Health Services | Office | 17 | 11 | $3.22 | $54.69 |
| G0008 Administration of influenza virus vaccine | Office | 17 | 16 | $29.78 | $506 |
| 82043 Clinical Chemistry | Office | 12 | 11 | $5.66 | $67.92 |
| 82570 Clinical Chemistry | Office | 12 | 11 | $5.08 | $60.96 |
By year: 2022 $25K for 570 services; 2023 $21K for 498 services; 2024 $26K for 646 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 62 | 31 | $6.86 | $425 |
| 83036 Blood Count | 26 | 16 | $9.52 | $248 |
| 80061 Clinical Chemistry | 24 | 21 | $13.12 | $315 |
| 85025 Blood Count | 22 | 19 | $7.61 | $167 |
| 82043 Clinical Chemistry | 12 | 11 | $5.66 | $67.92 |
| 82570 Clinical Chemistry | 12 | 11 | $5.08 | $60.96 |
Medicare prescription drug claims, 2024
In 2024, the drug Dacia D Oakeson prescribed most often to Medicare patients was Lisinopril, with 143 prescriptions and refills. In total Dacia D Oakeson wrote 3,819 Medicare prescriptions that cost $658K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lisinopril Generic | 143 | 288 | 29 | $967 |
| Gabapentin Generic | 135 | 212 | 24 | $3,089 |
| Atorvastatin Calcium Generic | 133 | 332 | 36 | $1,115 |
| Amlodipine Besylate Generic | 105 | 203 | 21 | $539 |
| Buspirone Hcl Generic | 88 | 126 | 18 | $1,435 |
| Trazodone Hcl Generic | 86 | 166 | 25 | $703 |
| Levothyroxine Sodium Generic | 85 | 200 | 18 | $852 |
| Ozempic Semaglutide | 83 | 88 | Under 11 | $84K |
| Omeprazole Generic | 80 | 157 | 17 | $1,674 |
| Lamotrigine Generic | 76 | 136 | 15 | $919 |
| Vraylar Cariprazine Hcl | 71 | 71 | 11 | $102K |
| Clonidine Hcl Generic | 71 | 84 | Under 11 | $415 |
| Clonazepam Generic | 68 | 70 | Under 11 | $1,173 |
| Fluoxetine Hcl Generic | 65 | 111 | 12 | $535 |
| Metformin Hcl Er Metformin Hcl | 64 | 97 | 11 | $755 |
Brand drugs: 662 claims; generic drugs: 3,134 claims; opioid claims: 89.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dacia D Oakeson $8,451 ($8,451 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $8,095.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $8,095 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $96.65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $72.3 |
| Pfizer Inc. PFE | 3 | $48.15 |
| Abiomed JNJ | 1 | $34.71 |
| Exact Sciences Corporation EXAS | 2 | $32.42 |
| Axsome Therapeutics, Inc. AXSM | 1 | $19.88 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $18.92 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $18.29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.